Mixed Connective Tissue Disease (MCTD)

  • Medical Author:
    William C. Shiel Jr., MD, FACP, FACR

    Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.

  • Medical Editor: Catherine Burt Driver, MD
    Catherine Burt Driver, MD

    Catherine Burt Driver, MD

    Catherine Burt Driver, MD, is board certified in internal medicine and rheumatology by the American Board of Internal Medicine. Dr. Driver is a member of the American College of Rheumatology. She currently is in active practice in the field of rheumatology in Mission Viejo, Calif., where she is a partner in Mission Internal Medical Group.

View RA Slideshow Pictures

What is the prognosis of mixed connective tissue disease?

The outlook for mixed connective tissue disease very much depends on the location and intensity of the organs affected. Those who are treated and monitored early tend to have better outcomes.

Is it possible to prevent mixed connective tissue disease?

No. There is no prevention for mixed connective tissue disease.

Are there support groups for mixed connective tissue disease?

See the local chapter of the Arthritis Foundation for information about support groups.

Medically reviewed by Aimee V. HachigianGould, MD; American Board of Orthopaedic Surgery

REFERENCES:

Koopman, William, et al., eds. Clinical Primer of Rheumatology. Philadelphia: Lippincott Williams & Wilkins, 2003.

Ruddy, Shaun, et al., eds. Kelley's Textbook of Rheumatology. Philadelphia: W.B. Saunders Co., 2000.

Medically Reviewed by a Doctor on 2/18/2015

Health Solutions From Our Sponsors